valproic acid and cortodoxone

valproic acid has been researched along with cortodoxone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altaher, AR; Gillham, B; Jenkins, JS; Jones, MT; Nussey, SS; Price, P	1
Bahtiyar, G; Sacerdote, AS; Weiss, K	1

Other Studies

2 other study(ies) available for valproic acid and cortodoxone

Article	Year
The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome. Clinical endocrinology, 1988, Volume: 28, Issue:4 Topics: Adrenocorticotropic Hormone; Adult; Aged; Cortodoxone; Cushing Syndrome; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Male; Middle Aged; Pyridines; Valproic Acid	1988
Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2007, Volume: 13, Issue:6 Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adult; Aged; Antipsychotic Agents; Cortodoxone; Dehydroepiandrosterone; Endocrine Disruptors; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Male; Metformin; Middle Aged; Radioimmunoassay; Rosiglitazone; Testosterone; Thiazolidinediones; Valproic Acid	2007

Article

Year

The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome.

Clinical endocrinology, 1988, Volume: 28, Issue:4

Topics: Adrenocorticotropic Hormone; Adult; Aged; Cortodoxone; Cushing Syndrome; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Male; Middle Aged; Pyridines; Valproic Acid

1988

Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2007, Volume: 13, Issue:6

Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adult; Aged; Antipsychotic Agents; Cortodoxone; Dehydroepiandrosterone; Endocrine Disruptors; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Male; Metformin; Middle Aged; Radioimmunoassay; Rosiglitazone; Testosterone; Thiazolidinediones; Valproic Acid

2007